Impfen Pro & Contra - Das Handbuch für die individuelle Impfentscheidung
decline associated with increasing vaccination coverage. Vaccine 2006, 24 (42–43): 6468–6475
RKI (Robert-Koch-Institut): Influenza. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten. 2010: 126–132
Safranek, T. J., Lawrence, D. N., Kurland, L. T., Culver, D. H., Wiederholt, W. C., Hayner, N. S., et al.: Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976–1977: results of a two-state study. Expert Neurology Group. Am J Epidemiol 1991, 133 (9): 940–951
Satoh, M., Kuroda, Y., Yoshida, H., Behney, K.M.: Induction of lupus autoantibodies by adjuvants. J Autoimmun 2003, 21 (1): 1–9
Skowronski, D. M., Jacobsen, K., Daigneault, J., Remple, V. P., et al.: Solicited adverse events after influenza immunization among infants, toddlers, and their household contacts. Pediatrics 2006, 117 (6): 1963–1971
Skull, S.A., Andrews, R. M., Byrnes, G. B., Kelly, H. A., et al.: Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: Benefit due to influenza and pneumococcal vaccination not demonstrated. Vaccine 2007, 25 (23): 4631–4640
Smith, S., Demicheli, V., Di Pietrantonj, C., Harnden, A. R., Jefferson, T., Matheson, N. J., et al.: Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2006 (1): CD 004879
Soriano, A., Verrecchia, E., Marinaro, A., Giovinale, M.: Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. Lupus 2012, 21 (2): 153–157
Souayah, N., Nasar, A., Suri, M. F., Qureshi, A. I.: Guillain-Barre syndrome after vaccination in United States – A report from the CDC / FDA Vaccine Adverse Event Reporting System. Vaccine 2007, 25 (29): 5253ff.
Spiegel Online: Schweinegrippe – Experte warnt vor Viren-Hysterie. 18.7.2009. http:// www.spiegel.de/wissenschaft/mensch/0,1518,636914,00.html (Zugriff 19. 1. 2011)
Stepanova, L. A., Linde, A., Naikhin, A. N., Bichurina, M. A., Paramonova, M. S.: Spetsificheskii immunnyi otvet na vaktsinatsiiu inaktivirovannoi grippoznoi vaktsinoi v zavisimosti ot prevaktsinal’nogo statusa i vozrasta vaktsiniruemykh (Specific immune response to vaccination with an inactivated flue vaccine depending on prevaccine status and age of the person vaccinated). Vopr Virusol 2000, 45 (2): 26–29
Tagesspiegel: Schweinegrippe: Höchste Warnstufe. 1.11.2009. http:// www.tagesspiegel.de/weltspiegel/experten-schweinegrippe-hoechste-warnstufe/1836418.html (Zugriff 25. 1. 2012)
Takahashi, T., Kanda, T., Yamaguichi, N.: Influenza vaccines. N Engl J Med 2007, 356 (11): 1172f.
Tavadia, S., Dummond, A., Evans, C. D., Wainwright, N. J.: Leucocytoclastic vasculitis and influenza vaccination. Clin Exp Dermatol 2003, 28 (2): 154ff.
Thurairajan, G., Hope-Ross, M. W., Situnayake, R. D., Murray, P. I.: Polyarthropathy, orbital myositis and posterior scleritis: an unusual adverse reaction to influenza vaccine. Br J Rheumatol 1997, 36 (1): 120–123
Time Health: Do Flu Vaccines Really Work? A Skeptic’s View. 27.2. 2010. http:// www.time.com/time/health/article/0,8599,1967306,00.html (Zugriff 25. 1. 2012)
Transparency International: »Schweinegrippe«-Impfung: Transparency kritisiert potenzielle Interessenkonflikte und intransparente Entscheidungsprozesse bei der Ständigen Impfkommission STIKO . Pressemitteilung, 14.9.2009. http:// www.transparency.de/2009-09-14-Schweinegrippe.1494.0.html (Zugriff 25. 1. 2012)
Vesikari, T., Knuf, M., Wutzler, P., Karvonen, A., et al.: Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011, 365 (15): 1406–1416
Watanabe, T.: Henoch-Schönlein purpura following influenza vaccinations during the pandemic of influenza A (H1N1). Pediatr Nephrol 2011, 26 (5): 795–798
Yamane, N., Uemura, H.: Serological examination of IgE- and IgG-specific antibodies to egg protein during influenza virus immunization. Epidemiol Infect 1988, 100 (2): 291–299
Yanai-Berar, N., Ben-Itzhak, O., Gree, J., Nakhoul, F.: Influenza vaccination induced leukocytoclastic vasculitis and pauci-immune crescentic glomerulonephritis. Clin Nephrol 2002, 58 (3): 220–223
Respiratorisches Synzytial-Virus
In diesem Kapitel geht es nicht um eine klassische Impfung, mit der die Bildung von Antikörpern angeregt wird, sondern um die direkte Gabe spezieller Antikörper gegen ein Virus. Eine Impfung gegen respiratorische
Weitere Kostenlose Bücher